All news
Recent Publications
- Unlocking the Full Potential of Global Drug Innovation Through the FDA's 505(b)(2) PathwayMay 2026
- Auxilius Pharma Announces USD 4 Million Series A Financing Round to Advance Development of AUX-001 for Chronic Stable AnginaDecember 3, 2025
- NanoGroup acquired a stake in Auxilius Pharma for PLN 7.5 million and entered the VAM segmentNovember 17, 2025
- Chronic angina costs more than you thinkJuly 7, 2025
- PharmaShots CXO Talks interview with Auxilius Pharma’s CEO Jed Litwiniuk, MHA, and CMO, Uwe Tigor, MDNovember 11, 2024
- AUX-001 Phase 1a results presented at European Society of Cardiology annual meeting 2024September 2, 2024
- Auxilius has started thinking about the stock exchangeJune 17, 2024
- CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShotsJune 5, 2024
- Auxilius Pharma to launch Phase 1b anti-anginal trial after IND applicationMarch 27, 2024
- Media Release: Pioneering Progress: Auxilius Pharma's AUX-001 Delivers Positive First-in-Human Pharmacokinetic & Safety Results in Anti-Anginal R&DMarch 15, 2024
- Angina: Auxilius Pharma Announces Successful Conclusion of First-in-Human Clinical Trial of AUX-001 for Treatment of Chronic Stable Angina PectorisMarch 15, 2024
- FirstWord Pharma: Pioneering Progress, Auxilius Pharma's AUX-001 Delivers Impressive First-in-Human Pharmacokinetic and Safety Results in Anti-Anginal R&DMarch 15, 2024
- Americans have Silicon Valley, Poland a biotech valley — cooperation with global giants is bearing fruitJanuary 26, 2023
- Auxilius sees a business in transferring genericsNovember 4, 2022
- Auxilius Pharma sets its sights on the USAMarch 9, 2021
